Guidance
Our Guidance explains the laws and regulations governing the development, manufacturing, marketing, and supply of therapeutic goods in Australia.
We recently introduced new features to improve your experience using Guidance on our website.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Audience
Topic
- (-) Import and export (9)
- (-) Unique Device Identification (UDI) hub (2)
- Advertising (32)
- Breast implant hub (1)
- Clinical trials (5)
- Committees and advisory bodies (2)
- Compliance and enforcement (30)
- Cosmetics (4)
- COVID-19 (11)
- Fees and payments (3)
- Labelling and packaging (26)
- Legislation (9)
- Manufacturing (41)
- Medicinal cannabis hub (4)
- Metal-on-metal hip replacement implants hub (1)
- Safety monitoring and information (46)
- Scheduling (national classification system) (6)
- Shortages and supply disruptions (3)
- Sunscreens (2)
- Vaping hub (5)
- Weight loss products (1)
Search
11 result(s) found, displaying 1 to 11
-
GuidanceThis guidance is to assist entities and individuals planning to export medicines (including prescription, over-the-counter (OTC) and complementary medicines) either for commercial supply, or for non-commercial purposes (for example, for a family member or friend).
-
GuidanceUnderstand the regulatory requirements for supplying UDI compliant medical devices in Australia
-
GuidanceTimeframes for supplying UDI compliant medical devices in Australia
-
GuidanceThis guidance is to assist you to apply for a Certificate of Free Sale or an Export Certificate for medical devices, including in-vitro diagnostic medical devices (IVDs) and Other Therapeutic Goods (OTGs).
-
GuidanceGuidance on specific criteria and paperwork required for submission to the TGA to ensure conformance with TGO 93.
-
GuidanceGuidance on the legislative, regulatory and good clinical practice requirements when conducting clinical trials in Australia using unapproved therapeutic goods.
-
GuidanceThis guidance describes the requirements for manufacturers and sponsors of faecal microbial transplant (FMT) products in TGO 105.
-
GuidanceGuidance for sponsors and manufacturers about pathways for exporting a ventilator from Australia.
-
GuidanceGuidance relating to the supply of in vitro diagnostic medical devices for the detection of COVID-19/SARS-CoV-2 infections.
-
GuidanceGuidance on the use of market authorisation evidence from comparable overseas regulators for medical device applications.
-
GuidanceGuidance about how to apply for a permit to export human substances under the Customs (Prohibited Exports) Regulations 1958.